Laurion Capital Management LP acquired a new position in USANA Health Sciences, Inc. (NYSE:USNA) during the first quarter, Holdings Channel reports. The fund acquired 8,229 shares of the company’s stock, valued at approximately $690,000.

Several other institutional investors have also recently modified their holdings of the company. Vanguard Group Inc. grew its position in shares of USANA Health Sciences by 10.7% in the 3rd quarter. Vanguard Group Inc. now owns 1,245,807 shares of the company’s stock worth $150,182,000 after buying an additional 120,709 shares during the last quarter. BlackRock Inc. grew its holdings in shares of USANA Health Sciences by 1.2% during the fourth quarter. BlackRock Inc. now owns 1,089,647 shares of the company’s stock worth $128,283,000 after buying an additional 13,320 shares in the last quarter. MERIAN GLOBAL INVESTORS UK Ltd grew its holdings in shares of USANA Health Sciences by 54.1% during the first quarter. MERIAN GLOBAL INVESTORS UK Ltd now owns 363,410 shares of the company’s stock worth $30,479,000 after buying an additional 127,543 shares in the last quarter. Norges Bank purchased a new stake in shares of USANA Health Sciences during the fourth quarter worth $35,531,000. Finally, Robeco Institutional Asset Management B.V. grew its holdings in shares of USANA Health Sciences by 3.4% during the first quarter. Robeco Institutional Asset Management B.V. now owns 246,416 shares of the company’s stock worth $20,665,000 after buying an additional 8,205 shares in the last quarter. 54.69% of the stock is currently owned by hedge funds and other institutional investors.

Shares of USNA stock opened at $73.92 on Friday. The stock has a market cap of $1.77 billion, a PE ratio of 14.33 and a beta of 0.30. USANA Health Sciences, Inc. has a twelve month low of $73.38 and a twelve month high of $137.95.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings results on Tuesday, April 30th. The company reported $1.01 earnings per share for the quarter, beating the consensus estimate of $0.99 by $0.02. The firm had revenue of $272.90 million for the quarter, compared to analysts’ expectations of $272.20 million. USANA Health Sciences had a net margin of 10.38% and a return on equity of 29.51%. The company’s revenue was down 6.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.19 EPS. Analysts expect that USANA Health Sciences, Inc. will post 5.18 earnings per share for the current year.

USNA has been the subject of a number of research reports. Tigress Financial initiated coverage on shares of USANA Health Sciences in a report on Tuesday, April 16th. They set a “buy” rating for the company. ValuEngine lowered shares of USANA Health Sciences from a “hold” rating to a “sell” rating in a report on Wednesday. Finally, Pivotal Research reaffirmed a “buy” rating and set a $105.00 target price on shares of USANA Health Sciences in a report on Wednesday, May 1st.

TRADEMARK VIOLATION WARNING: This report was originally posted by Watch List News and is the property of of Watch List News. If you are accessing this report on another publication, it was stolen and republished in violation of US & international copyright laws. The legal version of this report can be read at https://www.watchlistnews.com/8229-shares-in-usana-health-sciences-inc-usna-purchased-by-laurion-capital-management-lp/3022021.html.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition.

Featured Story: What is a Fibonacci Channel?

Want to see what other hedge funds are holding USNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for USANA Health Sciences, Inc. (NYSE:USNA).

Institutional Ownership by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.